Medicare Enrolled
Dr. Freidoon Ghazi, M.D.
Cardiovascular Disease · Cincinnati, OH
Practice pattern: Electrophysiology & Remote
— Practice combining electrophysiology and remote services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ghazi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ghazi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ghazi
Dr. Freidoon Ghazi is a cardiovascular disease specialist in Cincinnati, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ghazi performed 3,426 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ghazi received a total of $72,540 from 42 pharmaceutical and/or device companies across 465 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ghazi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in OH
$72,540 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,426
Medicare services
Top 14% in OH for cardiovascular disease
Not available
Unique patients (not deduplicated)
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
772 | $6 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
623 | $79 | $235 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
376 | $9 | $56 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
244 | $47 | $142 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
180 | $14 | $70 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
175 | $90 | $232 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
149 | $19 | $85 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
104 | $126 | $451 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
88 | $19 | $83 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
88 | $62 | $170 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
83 | $59 | $144 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
66 | $2 | $9 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
48 | $79 | $313 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $48 | $158 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $116 | $317 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
40 | $83 | $501 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
33 | $58 | $161 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
32 | $16 | $56 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
32 | $11 | $36 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
32 | $33 | $88 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
32 | $16 | $66 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
31 | $24 | $169 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
29 | $36 | $92 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
21 | $19 | $58 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
18 | $5 | $16 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
14 | $13 | $67 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
14 | $13 | $46 |
| Stress echocardiogram An ultrasound of the heart performed while at rest and during exercise or drug-induced stress to evaluate heart function under different conditions. |
11 | $48 | $160 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
21.8% high complexity
6.1% medium
72.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$72,540
Total received (2018-2024)
Avg $10,363/year across 7 years
Top 7% in OH for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
465
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,256
2023
$1,291
2022
$1,681
2021
$4,262
2020
$15,623
2019
$24,528
2018
$23,898
Payments by company (2024)
Boston Scientific Corporation
$226
AstraZeneca Pharmaceuticals LP
$189
Novartis Pharmaceuticals Corporation
$150
ANI Pharmaceuticals, Inc.
$125
Actelion Pharmaceuticals US, Inc.
$121
Amgen Inc.
$89
Daiichi Sankyo Inc.
$66
PFIZER INC.
$64
SCPHARMACEUTICALS INC.
$63
Alnylam Pharmaceuticals Inc.
$52
Bayer Healthcare Pharmaceuticals Inc.
$41
LANTHEUS MEDICAL IMAGING, INC.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Lexicon Pharmaceuticals, Inc.
$15
Janssen Pharmaceuticals, Inc
$11
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$34,624
AstraZeneca Pharmaceuticals LP
$15,596
Novartis Pharmaceuticals Corporation
$9,987
Boston Scientific Corporation
$5,812
BOSTON SCIENTIFIC CORPORATION
$1,956
Amarin Pharma Inc.
$573
Medtronic Vascular, Inc.
$429
Boehringer Ingelheim Pharmaceuticals, Inc.
$348
Amgen Inc.
$333
Merck Sharp & Dohme LLC
$293
Abbott Laboratories
$276
PFIZER INC.
$228
Edwards Lifesciences Corporation
$167
CVRx, Inc.
$164
E.R. Squibb & Sons, L.L.C.
$143
Bayer Healthcare Pharmaceuticals Inc.
$141
ANI Pharmaceuticals, Inc.
$125
ABIOMED
$125
Actelion Pharmaceuticals US, Inc.
$121
Daiichi Sankyo Inc.
$121
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$116
Esperion Therapeutics, Inc.
$111
Janssen Scientific Affairs, LLC
$95
Lilly USA, LLC
$94
SCPHARMACEUTICALS INC.
$63
iRhythm Technologies, Inc.
$60
Novo Nordisk Inc
$53
Alnylam Pharmaceuticals Inc.
$52
Regeneron Healthcare Solutions, Inc.
$50
ARALEZ PHARMACEUTICALS US INC.
$45
Vifor Pharma, Inc.
$36
Inari Medical, Inc.
$25
Cook Medical LLC
$24
Gilead Sciences, Inc.
$24
Bayer HealthCare Pharmaceuticals Inc.
$24
LANTHEUS MEDICAL IMAGING, INC.
$23
SANOFI-AVENTIS U.S. LLC
$17
Roche Diagnostics Corporation
$16
Lexicon Pharmaceuticals, Inc.
$15
Terumo Medical Corporation
$13
Lundbeck LLC
$12
Kowa Pharmaceuticals America, Inc.
$11
Top 3 companies account for 83.0% of all-time payments
Associated products mentioned in payments ›
ACCOLADE SR · AMVUTTRA · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOMEMS · CoreValve Evolut · Corlanor · DEFINITY · ELIQUIS · ENTRESTO · EVKEEZA · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FLOWTRIEVER CATHETER · FUROSCIX · GENERAL BRADY · INGEVITY MRI · INGEVITY+ · INJECTAFER · INVOKANA · Impella · JARDIANCE · Kerendia · LATITUDE Communicator Power Supply · LEQVIO · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · NEXLIZET · NORTHERA · Ozempic · POC CoaguChek Meters · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PURIFIED CORTROPHIN GEL · RESONATE EL ICD VR · Repatha · Rybelsus · S · Strips and Accessories · TR Band · UPTRAVI · VERQUVO · VIGILANT X4 CRT-D · VYNDAMAX · VYNDAQEL · Vascepa · Veltassa · Viva · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO XT Patch · ZONTIVITY · Zilver Vena · myLUX Patient Kit with mobile device
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
154
County median income
$70,816
Nearest hospital to ZIP centroid (approximate)
CINCINNATI VA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ghazi is an electrophysiology & remote specialist, with above-average Medicare volume (top 14% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ghazi experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Ghazi performed 772 ekg interpretation and report services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ghazi receive payments from pharmaceutical companies?
Yes. Dr. Ghazi received a total of $72,540 from 42 companies across 465 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ghazi's costs compare to other cardiologists in Cincinnati?
Dr. Ghazi's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ghazi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Cincinnati
Browse cardiologists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in OH
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in OH
Which OH cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology